A detailed history of Quest Partners LLC transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 10,918 shares of PHAT stock, worth $101,974. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,918
Holding current value
$101,974
% of portfolio
0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$10.25 - $19.5 $111,909 - $212,901
10,918 New
10,918 $197 Million
Q4 2023

Feb 09, 2024

BUY
$6.99 - $10.71 $15,412 - $23,615
2,205 New
2,205 $20.1 Million

Others Institutions Holding PHAT

About Phathom Pharmaceuticals, Inc.


  • Ticker PHAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,175,200
  • Market Cap $366M
  • Description
  • Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...
More about PHAT
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.